Teva Can't Dodge GSK's Wellbutrin False Ad Suit
A Pennsylvania federal judge refused Monday to dismiss GlaxoSmithKline LLC's lawsuit accusing Teva Pharmaceuticals USA Inc. of falsely advertising a generic antidepressant as equivalent to GSK's brand-name version, saying it was...To view the full article, register now.
Already a subscriber? Click here to view full article